hansoh glp 1 REAL-WORLD EVIDENCE OF GLP-1RAS PUBLISHED IN AN INTERNATIONAL JOURNAL REVEALS BETTER OPTION PHARMA'S FULAIMEI PROVIDES FOR DKD PATIENTS-Press Releases-Hansoh Pharmaceutical Group Co., Ltd New Competition in the GLP-1

GLP-1 medications are typically considered for adults who: Have a Body Mass Index (BMI) of 30 or higher Have a BMI of 27 or higher with weight-related conditions such as diabetes or hypertension Have not achieved sustained weight loss through lifestyle modification alone These medications are intended for long-term weight management, not short-term or cosmetic weight loss

He is the same physician who reviews your labs, sets your titration schedule, and signs off on every dose change, rather than a rotating panel of remote providers

(2025) 19:jjaf167

The Step 1 Trial 12 found using GLP-1 for more than 1 year resulted in a loss of 15.3 kg or 14.9% of initial body weight